Guanidine Hydrazone (2a): A Novel Disease-Modifying Treatment for Parkinson's Disease

被引：0
|
作者：
Persico, Michele [1 ]
Fang, Tracy Shi Zhang [1 ]
Eleuteri, Simona Carmen [1 ]
Simon, David Keith [1 ]
机构：
[1] Harvard Med Sch, Beth Israel Deaconess Med Ctr, Boston, MA USA
来源：
ANNALS OF NEUROLOGY | 2023年 / 94卷
关键词：
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
S221
引用
收藏
页码：S174 / S174
页数：1
相关论文
共 50 条
  • [21] The search for disease-modifying treatment for Alzheimer's disease
    Aisen, PS
    Davis, KL
    NEUROLOGY, 1997, 48 (05) : S35 - S41
  • [22] Delivering a disease-modifying treatment for Huntington's disease
    Godinho, Bruno M. D. C.
    Malhotra, Meenakshi
    O'Driscoll, Caitriona M.
    Cryan, John F.
    DRUG DISCOVERY TODAY, 2015, 20 (01) : 50 - 64
  • [23] Disease-modifying treatment approaches for Alzheimer's disease
    Froelich, Lutz
    Hausner, Lucrezia
    NERVENARZT, 2021, 92 (12): : 1239 - 1248
  • [24] Translating scientific advances into disease-modifying therapies for Parkinson's Disease
    Cenci, M. Angela
    Olanow, C. Warren
    EXPERIMENTAL NEUROLOGY, 2017, 298 : 135 - 136
  • [25] Enhancement of glycolysis: A potential disease-modifying strategy for Parkinson's disease
    Morales-Briceno, Hugo
    Fung, Victor S. C.
    MOVEMENT DISORDERS, 2020, 35 (01) : 81 - 81
  • [26] Does Rasagiline Have a Disease-Modifying Effect on Parkinson’s Disease?
    Shyamal H. Mehta
    John C. Morgan
    Kapil D. Sethi
    Current Neurology and Neuroscience Reports, 2010, 10 (6) : 413 - 416
  • [27] α-Synuclein antisense oligonucleotides as a disease-modifying therapy for Parkinson's disease
    Cole, Tracy A.
    Zhao, Hien
    Collier, Timothy J.
    Sandoval, Ivette
    Sortwell, Caryl E.
    Steece-Collier, Kathy
    Daley, Brian F.
    Booms, Alix
    Lipton, Jack
    Welch, Mackenzie
    Berman, Melissa
    Jandreski, Luke
    Graham, Danielle
    Weihofen, Andreas
    Celano, Stephanie
    Schulz, Emily
    Cole-Strauss, Allyson
    Luna, Esteban
    Quach, Duc
    Mohan, Apoorva
    Bennett, C. Frank
    Swayze, Eric E.
    Kordasiewicz, Holly B.
    Luk, Kelvin C.
    Paumier, Katrina L.
    JCI INSIGHT, 2021, 6 (05)
  • [28] CDNF: An innovative actor in disease-modifying approaches for Parkinson's disease
    Tenenbaum, Liliane
    MOLECULAR THERAPY, 2021, 29 (09) : 2634 - 2636
  • [29] Parkinson's disease subtypes and their relevance to studies of disease-modifying agents
    Elm, J.
    Bergmann, K.
    Tilley, B.
    Goudreau, J.
    Salak, V.
    Weiner, W.
    Aminoff, M.
    Shulman, L.
    Cambi, F.
    Kieburtz, K.
    PARKINSONISM & RELATED DISORDERS, 2009, 15 : S61 - S61
  • [30] A new approach to disease-modifying drug trials in Parkinson's disease
    Barker, Roger A.
    Stacy, Mark
    Brundin, Patrik
    JOURNAL OF CLINICAL INVESTIGATION, 2013, 123 (06): : 2364 - 2365
12345